PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 14, 2015Nucleic Acids Research111 citationsOpen Access

Sequences spanning the leader-repeat junction mediate CRISPR adaptation to phage in Streptococcus thermophilus

View Full Paper
YWYunzhou WeiMCMegan T. ChesneRTRebecca M. Terns

Key Points

Key points are not available for this paper at this time.

Abstract

CRISPR-Cas systems are RNA-based immune systems that protect prokaryotes from invaders such as phages and plasmids. In adaptation, the initial phase of the immune response, short foreign DNA fragments are captured and integrated into host CRISPR loci to provide heritable defense against encountered foreign nucleic acids. Each CRISPR contains a ∼100-500 bp leader element that typically includes a transcription promoter, followed by an array of captured ∼35 bp sequences (spacers) sandwiched between copies of an identical ∼35 bp direct repeat sequence. New spacers are added immediately downstream of the leader. Here, we have analyzed adaptation to phage infection in Streptococcus thermophilus at the CRISPR1 locus to identify cis-acting elements essential for the process. We show that the leader and a single repeat of the CRISPR locus are sufficient for adaptation in this system. Moreover, we identified a leader sequence element capable of stimulating adaptation at a dormant repeat. We found that sequences within 10 bp of the site of integration, in both the leader and repeat of the CRISPR, are required for the process. Our results indicate that information at the CRISPR leader-repeat junction is critical for adaptation in this Type II-A system and likely other CRISPR-Cas systems.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wei et al. (2015) studied this question.

synapsesocial.com/papers/6a63ba46809dd4a9e2c1f9f9https://doi.org/10.1093/nar/gku1407
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Protospacer recognition motifs2013 · 362 citations
  2. 2Evolution and classification of the CRISPR–Cas systems2011 · 2,535 citations
  3. 3Inter‐viral conflicts that exploit host CRISPR immune systems of S ulfolobus2013 · 71 citations
  4. 4Double-strand DNA end-binding and sliding of the toroidal CRISPR-associated protein Csn22013 · 53 citations
  5. 5CRISPR interference: a structural perspective2013 · 128 citations